Report: Reimbursement codes block innovative surgical techniques

June 7, 2010 by MassDevice staff

Commercialization costs and bureaucratic red tape keep device makers from bringing more advanced minimally invasive surgical techniques into the spectrum of care, according to a report from design and engineering firm Cambridge Consultants.

Cambridge Consultants logo

Entrepreneurs in the minimally invasive surgery space might wait 12 years for their product to become profitable, but there's another costly bottom line as well: patient's well being. While medical technology waits for government approval and adoption by healthcare providers, patients wait as well. Because technological development is leaving the approval process in the dust, doctors can't provide their patients with the most advanced products.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.